LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article: Immunogenic and Protective Properties of Recombinant Hemagglutinin of Influenza A (H5N8) Virus.

Rudometova, Nadezhda B / Fando, Anastasia A / Kisakova, Lyubov A / Kisakov, Denis N / Borgoyakova, Mariya B / Litvinova, Victoria R / Yakovlev, Vladimir A / Tigeeva, Elena V / Vahitov, Danil I / Sharabrin, Sergey V / Shcherbakov, Dmitriy N / Evseenko, Veronika I / Ivanova, Ksenia I / Gudymo, Andrei S / Ilyicheva, Tatiana N / Marchenko, Vasiliy Yu / Ilyichev, Alexander A / Rudometov, Andrey P / Karpenko, Larisa I

Vaccines

2024  Volume 12, Issue 2

Abstract: In this study, we characterized recombinant hemagglutinin (HA) of influenza A (H5N8) virus produced in Chinese hamster ovary cells (CHO-K1s). Immunochemical analysis showed that the recombinant hemagglutinin was recognized by the serum of ferrets ... ...

Abstract In this study, we characterized recombinant hemagglutinin (HA) of influenza A (H5N8) virus produced in Chinese hamster ovary cells (CHO-K1s). Immunochemical analysis showed that the recombinant hemagglutinin was recognized by the serum of ferrets infected with influenza A (H5N8) virus, indicating that its antigenic properties were retained. Two groups of Balb/c mice were immunized with intramuscular injection of recombinant hemagglutinin or propiolactone inactivated A/Astrakhan/3212/2020 (H5N8) influenza virus. The results demonstrated that both immunogens induced a specific antibody response as determined by ELISA. Virus neutralization assay revealed that sera of immunized animals were able to neutralize A/turkey/Stavropol/320-01/2020 (H5N8) influenza virus-the average neutralizing titer was 2560. Immunization with both recombinant HA/H5 hemagglutinin and inactivated virus gave 100% protection against lethal H5N8 virus challenge. This study shows that recombinant HA (H5N8) protein may be a useful antigen candidate for developing subunit vaccines against influenza A (H5N8) virus with suitable immunogenicity and protective efficacy.
Language English
Publishing date 2024-01-29
Publishing country Switzerland
Document type Journal Article
ZDB-ID 2703319-3
ISSN 2076-393X
ISSN 2076-393X
DOI 10.3390/vaccines12020143
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top